NCT00301392View on ClinicalTrials.gov

Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT)

PHASE4CompletedINTERVENTIONAL
Enrollment

1,240

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

March 31, 2012

Study Completion Date

June 30, 2012

Conditions
Diabetes MellitusGlucose Intolerance
Interventions
OTHER

life-style intervention

As the life-style interventions aiming to reduce the major risks of developing diabetes mellitus, instruct the following four items:(1)set diet right, (2)maintain normal weight,(3)improve physical activity,(4)normalize smoking and alcohol drinking.

DRUG

Life style interventions plus concomitant use of pitavastatin.

Once-daily dosing of pitavastatin 1 mg(1 tablet of Livalo Tab 1 mg), or 2mg(2 tablets of Livalo Tab 1mg or 1 tablet of Livalo Tab 2mg);Dosing period of pitavastatin should be 60 months.(max.84 months).

Trial Locations (1)

113-8655

The University of Tokyo, Graduate School of Medicine, Bunkyo-ku

All Listed Sponsors
lead

Tokyo University

OTHER

NCT00301392 - Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT) | Biotech Hunter | Biotech Hunter